Meet the companies and academic groups
There are currently about 25 life science companies and academic groups co-locating at the heart of AstraZeneca’s R&D Gothenburg site. Each new company or academic group adds more ingredients and flavours to the innovative future we’re creating and nurturing in the BioVentureHub community.
By daring to share and stimulating and sustainable life science reality – combining Drugs, MedTech, Diagnostics, Data & AI, Digital health, Expert Providers and Academia – we are forming a modern, life science environment, based on scientific curiosity and collaboration opportunities, rather than strict business plan recipes. This is where you go from challenges to opportunities.
Companies and Academic Groups
Albus Health
Albus Health makes contactless nocturnal monitoring systems (Albus Home) that automatically monitor a range of physiological and environmental metrics without the patients having to do or wear anything. Using a small bedside device and a range of algorithms, the system monitors metrics such as respiration, coughing and wheezing, as well as information such as air quality, temperature and humidity. Whether it's a 5 year-old child or a 95 year-old elderly, Albus Home can be used with anyone, anywhere and as long as needed. This helps collect continuous and objective evidence from participants' homes in clinical trials without needing clinical visits. In healthcare, it provides exciting opportunities for continuous monitoring of a range of chronic conditions to provide a diagnosis as well as early warning signs of worsening several days prior to an emergency, so patients can stay healthy at home
Links and case studies
Visit Albus Healths website
Amferia
Amferia’s proprietary patented technology is a new and effective antibacterial material. The material consists of bioinspired and amphiphilic antibacterial polymers that target and rapidly kill bacteria upon contact, including numerous antibiotic resistant bacteria like MRSA and MDR E. Coli.
Links and case studies
Visit Amferia's website
Meet Saba Atefyekta, a BioVentureHub community member from Amferia.
Biomatter
Biomatter is a premier enzyme design company that bridges the gap between generative AI and real-world industrial applications. Through the proprietary Intelligent Architecture™ platform, the company combines physics-based modeling with artificial intelligence to engineer previously impossible enzymes from the bottom up. Trusted by global industry leaders, Biomatter partners on end-to-end development - integrating computational design with a wet-lab validation loop - to create custom enzymes that drive commercial success across industrial biotech, biopharma, and life sciences.
Links and case studies
Visit Biomatters website
CCRM Nordic
CCRM Nordic supports academic and industrial Advanced Therapy Medicinal Products (ATMP) developers - ranging from small startups to large organizations - in translating research and early-stage clinical programs into effective treatments for patients. CCRM Nordic offers a comprehensive range of services for ATMPs, including business creation, strategic advice, early-stage process and analytical development, and, in the near future, clinical manufacturing. As a not-for-profit organization, CCRM Nordic is at the core of Sweden’s strategic vision for leadership in life sciences and to accelerate the translation and commercialization of ATMPs.
Links and case studies
Visit CCRM Nordics website
Datametrix
Founded in 2003, datametrix is a Swiss clinical research organization with a strong heritage in statistical analysis and programming, clinical data management and medical writing. With more than 13 years of experience, we are well-established alternative to top tier CROs, delivering high quality and cost-effective services to pharmaceutical, life science and biotech industries.
Links and case studies
Visit Datametrix's website
Emeriti Bio
Emeriti Bio AB is a privately held sister company to Emeriti Pharma AB. The focus is on novel treatment options for heavy menstrual bleeding. Emeriti Bio AB is also developing molecules for validated pharmaceutical drug targets in different areas. Finally, Emeriti Bio AB provides consultancy services in chemistry, drug discovery and drug development.
Links and case studies
IFLAI
IFLAI builds data- and energy-efficient AI for imaging and video analytics. Spun out of the Departments of Physics at Chalmers University of Technology and the University of Gothenburg, our approach fuses physics and AI to build models that reach high accuracy with a small fraction of the data and cost, and adapt to new instruments or environments quickly on standard, local hardware. We help pharma, medtech and niotech teams automate demanding visual tasks (e.g., cell analysis, defect detection, tracking) with small, traceable models that are easy to integrate on-premise, on-cloud or on-edge.
Links and case studies
Visit IFLAI's website
Meet Henrik Klein Moberg, a BioVentureHub community member from IFLAI.
IonQ
IonQ, a leader in the exciting, and fast growing quantum computing sector, has the expressed mission to build the world’s best quantum computers, to solve the world’s most complex problems, transforming business, society, and the planet for the better. Their unique trapped-ion approach combines unique physical performance, perfect qubit replication, optical networkability, and highly-optimized algorithms to create a quantum computer that is as scalable as it is powerful, and that will support a broad array of applications across a variety of industries.
Links and case studies
Visit IonQ's website
Kromnigon
Kromnigon AB develops a new generation of reagents for multicolor microscopy based on its patented technology StreptaClick. The field of multicolor microscopy has skyrocketed due to personalized medicine and its need for understanding cell interactions in tissues. Kromnigon was founded in 2015 and has since been supported by for example GU Ventures, Vinnova, and Almi. We have several new products on the way and will during 2022 raise new capital to expand marketing.
Links and case studies
Visit Kromnigon's website
Read more about how Kromnigon contribute to the BioVentureHub "Dare-to-Share" Culture for life science innovation. Link to Impact Story.
Lab Donkey
Lab Donkey is a UK-based laboratory automation software company helping scientists connect and coordinate diverse laboratory equipment into flexible, reliable workflows. Its hardware-agnostic orchestration platform brings instruments, robots, storage systems, and other devices from different manufacturers into a single, intuitive control environment, making it easier for laboratories to automate complex processes without being limited to one vendor ecosystem. Scientists can design multi-step workflows through a visual interface, while the software manages the underlying complexity of timing, labware movement, instrument state, scheduling, and handoffs between devices. By turning laboratory procedures into coordinated digital workflows, Lab Donkey helps teams reduce manual coordination, improve consistency, and get more value from both existing and future automation infrastructure.
Links and case studies
Visit Lab Donkey's' website
NaDeNo
NaDeNo Nanoscience aim to revolutionize cancer care by transforming how life-saving drugs reach their targets. NaDeNo’s proprietary PACA technology platform is suited for improved delivery of water-insoluble drugs in general. The patented one-step manufacturing method enables efficient drug solubilization and simultaneous incorporation into nanoparticles, while also allowing for the tailoring of particle surface properties to the intended use. This opens up numerous opportunities to revive potent drugs where other formulations have failed and for patent expansion of novel therapeutics combined with PACA.
NaDeNo - Transforming cancer care, one nanoparticle at a time.
Links and case studies
Visit NaDeNo's website
Meet Ýrr Mørch a BioVentureHub community member from NaDeNo.
NanoSIMS
Chalmers University of Technology/Gothenburg University have located their NanoSIMS laboratory in the BioVentureHub. The lab offers unique, ultra-high spatial chemical imaging giving true sub-cellular localisation of molecules in cells and tissue, as well as quantitative isotopic imaging for many other applications ranging from geology to materials science.
Links and case studies
Visit NanoSIMS' website
Read NanoSIMS Impact Story.
NordicRWE
NordicRWE, an emerging company specializing in real-world evidence (RWE) generation, has officially become a member of AstraZeneca's BioVentureHub, marking an important milestone in the company's journey. NordicRWE's focus on real-world evidence analytics and insights aligns seamlessly with the industry's growing demand for data-driven decision-making. By leveraging Nordic real-world data and advanced analytics and cutting-edge methodologies, NordicRWE is developing solutions that support data-driven drug development.
Links and case studies
Visit NordicRWE' website
Meet Steinar Thoresen, a BioVentureHub community member from NordicRWE.
Nyctea Technologies
Nyctea Technologies is developing and commercializing a new purification technology that aims to remove significant bottlenecks in today's process, producing pure biopharmaceuticals with minimal yield loss and without the use of harmful chemicals or large volumes of water. The mission is to lower the cost and increase the speed of production of biological pharmaceuticals and to accelerate the development of the next generation of medical treatments.
Nyctea Technologies come from Chalmers University of Technology.
Links and case studies
Visit Nyctea's website
Read Nyctea Technologies Impact Story.
Meet Gustav Ferrand Drake, a BioVentureHub community member from Nyctea Technologies.
OligoNova
OligoNova is a Swedish initiative addressing challenges in Research & Development of therapeutic oligonucleotides and supporting the development of novel therapies. OligoNova has the vision to deliver R&D innovations that will result in new patents, start-up companies and innovate treatments to patients.
Links and case studies
Visit Oligonova's website
Quris AI
Quris is an artificial intelligence innovator that is disrupting the drug development process.
Quris' Bio-AI Clinical Prediction Platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials.
We are led by a team of top scientists and strategic investors and are actively preparing for clinical testing with our first AI-based drug.
Links and case studies
Visit Quris AI's website
Retein
Retein’s patented filters for molecular precision recovery of waterborne resources target a wide range of application areas, including battery recycling, dialysis, and pharma. In their expanding lineup of energy-efficient filters, Retein uses biomimicry to enable circular use of resources like clean water, metals, and nutrients while removing the tiniest of pollutants.
Links and case studies
Visit Retein website
Meet Florian Schmitz, a BioVentureHub community member from Retein.
Scantox
Scantox offer bespoke analyses within organic chemistry.We develop customer specific analysis methods for characterization and quantification of organic substances for producers and importers of primarily pharmaceuticals and medical device. While specializing in method development on chromatography/mass spectrometry instruments we also have equipment for batch control/release testing of pharmaceuticals or pharm dev. We are audited for applicable parts of GMP, GLP & GCP.
Simsen Diagnostics
Simsen Diagnostics is a Swedish biotech company that specializes in ultrasensitive technologies for cancer monitoring. Founded in 2020, their mission is to make cancer a curable disease.
Simsen Diagnostics has developed an ultrasensitive sequencing platform that can be used in a wide range of applications. Simsen Personal™ is used to analyse circulating tumor DNA (ctDNA), and custom designed for each patient to help identify relapse earlier than standard-of-care tools. The use of ctDNA as a predictive biomarker for molecular residual disease (MRD) following treatment for solid tumors is rapidly being integrated into clinical trial design and translational research studies worldwide.
Links and case studies
Visit Simsen Diagnostics website
Synergon
Synergon offers qualified strategic Intellectual Property (IP) advice and IP portfolio management, with a focus on patents, trademarks and trade secrets. Our strength lies in the Life Science area, specifically in pharmaceuticals, biotechnology and Medtech, as well as in digital innovations. We see the big picture around IP, always maintaining a business-oriented perspective in order to ensure a cost efficient and commercially relevant IP protection for our clients.
Links and case studies
Visit Synergon's website
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivalled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Links and case studies
Visit Thermo Fisher Scientific's website
Waters Corporation
Waters Corporation, a leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Links and case studies
Visit Waters' website
Read Waters Impact Story.
BioVentureHub Alumnis at GoCo
BioVentureHub Alumnis at GoCo Health Innovation City
Alzinova
Alzinova AB is a Swedish clinical-stage company specializing in the treatment of Alzheimer’s disease – one of the major health scourges, without effective treatment options.
Alzheimer’s is one of the most common and devastating neurological diseases globally, with of the order of 40 million people afflicted today.
The company was founded by scientists at the University of Gothenburg, Sweden, in 2011 after the invention of a unique technology platform.
Links and case studies
Visit Alzinova's website
Antaros Medical was founded in 2014 by four entrepreneurs with extensive backgrounds in science and drug development as well as a shared commitment to defying convention. Their mission was to utilize innovative imaging to provide critical evidence-based decision support for pharma companies in clinical development phase.
Today, they have established themselves as a strategic development partner to the pharmaceutical industry. They combine groundbreaking imaging with profound experience of drug development and a deep knowledge in disease mechanisms. Together they have created solutions that few others can.
Links and case studies
Visit Antaros Medicals website
Cereno Scientific is a pioneering clinical-stage biotech company developing innovative treatments to enhance and extend the lives of patients with diseases that have high unmet medical needs.
Links and case studies
Visit Cereno Scientific website
I-Tech, a Swedish bio-technology company specializing in marine coatings, experienced significant growth and development during its time at AstraZeneca's BioVentureHub from 2015 to 2023. Today, I-Tech supplies paint manufacturers with an alternative antifouling ingredient for marine coatings that delivers superior barnacle fouling prevention at ultra-low concentrations with a unique non-lethal, bio-repellent mode of action.
I-Tech is an active BioVentureHub alumni company, situated at GoCo House.
Links and case studies
Visit I-Tech website
Check I-Tech Impact Story.
Intelligent Implants, acting in the Intersection of Digital Medicine and Orthopedics, is working on the future of electrotherapeutic orthopedic devices with a mission to develop a pipeline of smart, cloud-connected implants that can accelerate, control, and remotely monitor bone growth. Their aim is to reduce healing times, engage patients & surgeons, enable digital surgery/robotics and ultimately improve outcomes for millions of patients.
Links and case studies
Visit Intelligent Implants website
Mölnlycke is a world leading medical solutions company. We develop and bring to market innovative wound care and surgical solutions along the entire continuum of care – from prevention to post-acute settings. Learn more at www.molnlycke.com
Links and case studies
Visit Mölnlycke Health Care website
Read more about our partnership.
OnDosis is an AstraZeneca spin-out founded in Gothenburg in 2017.
Their mission is to revolutionize how patients take their medicines, and their plan is to get a first approval in the US in 2025, in cooperation with a leading Pharma.The team is today over 20 people strong across software, hardware, IoT, testing, mechanics, usability, quality, regulatory and supply chain. OnDosis is headquartered in the GoCo House in Mölndal, Sweden
Links and case studies
Visit OnDosis website
Check OnDosis Impact Story
Link to Impact Story Video
Promimic has developed a state-of-the-art nanotechnology that mimics nature, making it possible to create a unique bioactive surface on any implant.
From 2016 to 2023, when Promimic grew out of the facitlities and moved to GoCo House, they underwent significant expansion within the BioVentureHub.
Now Promimic operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets. Promimic continues to network with neighboring companies in the GoCo House, particularly on matters related to the labs.
Links and case studies
Visit Promimics website
Check Promimics Impact Story.